Indication: Gliclazide is indicated for the treatment of non insulin dependent diabetes mellitus (NIDDM) of patients who require oral antidiabetic treatment.

Dosage & Administration:

Oral route: The usual initial dose is 40 to 80 mg daily. The dose can be increased upto 320 mg daily in divided doses when needed. The drug should be taken before meal. For children Gliclazide is not used because it is contraindicated in juvenile- onset diabetes.

Preparation:

Diaseal^® 80 Tablet:  Each box contains 3x10’s Tablets in blster strip